Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BHV-1400 in IgA Nephropathy
NCT07642050Phase 3Not yet recruiting
- Sponsor
- Biohaven Ltd.
- Start
- Jun 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 3 trial of BHV-1400 in IgA nephropathy (IgAN), sponsored by Biohaven Ltd.. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
BHV-1400
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT07642050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07642050.